Innovation requires collaboration
Our mission is to have a significant impact on healthcare. We aim to be a front runner in the development of sustainable, innovative, and affordable healthcare.
What we do
Enzyre closes Series A financing round of €12M to advance pioneering diagnostic technology platform for hemophilia patients2 November 2022
Enzyre has announced that it has successfully raised €12 million in a Series A financing led by new investor, Oost NL, with participation from i&i Biotech Fund, Demcon Investment, Takeda Ventures, and Novalis Biotech. Part of the funding is an Innovation Credit from the Dutch Government.
SPL Medical announces collaboration with NanoEcho for application of Ferrotran® (Ferumoxtran) for Ultrasound detection of Lymph node metastases30 September 2022
SPL medical and NanoEcho have signed a Letter of Intent and initiated a cooperation on regulatory partnership and supply for SPL medical proprietary iron-based nanoparticle Ferrotran® (Ferumoxtran) product and platform.